Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development and Clinical Translation of immunoPET Imaging Probes for Digestive System Carcinoma

NCT06715839 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06715839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06715839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development and Clinical Translation of immunoPET Imaging Probes for Digestive System Carcinoma
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2024
Completion date
September 30, 2027
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appendix cancer, bile duct carcinoma, colon cancer, digestive cancer, digestive system cancer, digestive system carcinoma, digestive system neoplasm, esophagus cancer, gallbladder carcinoma, liver cancer, malignancy, pancreatic cancer, rectum cancer, small intestine cancer, stomach cancer